Inventor
BRISTOL J ANDREW
US16 patents
⚠️ This page may combine multiple inventors who share the name “BRISTOL J ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PREC BIOLOGICS INC
8 patentsUS10023650B2Jul 17, 2018
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
PREC BIOLOGICS INC5 citations83
US10364295B2Jul 30, 2019
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
PREC BIOLOGICS INC3 citations82
US9605077B2Mar 28, 2017
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
PREC BIOLOGICS INC5 citations82
US11952429B2Apr 9, 2024
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
PREC BIOLOGICS INC2 citations72
US11401341B2Aug 2, 2022
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
PREC BIOLOGICS INC2 citations72
US11572413B2Feb 7, 2023
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
PREC BIOLOGICS INC1 citations71
US12344676B2Jul 1, 2025
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
PREC BIOLOGICS INC0 citations62
US12460013B2Nov 4, 2025
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
PREC BIOLOGICS INC0 citations60
NEOGENIX ONCOLOGY INC
3 patentsUS7314622B2Jan 1, 2008
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
NEOGENIX ONCOLOGY INC111 citations96
US7829678B2Nov 9, 2010
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
NEOGENIX ONCOLOGY INC30 citations94
US7763720B2Jul 27, 2010
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
NEOGENIX ONCOLOGY INC18 citations88